Filing Flows › Ginkgo Bioworks Holdings (DNA) › Q2 2025
Ginkgo Bioworks Holdings (DNA) Q2 2025 earnings results (second quarter 2025)
10-Q filed Aug 7, 2025
Ginkgo Bioworks Holdings (DNA) reported revenue of $49.6M for the second quarter 2025 (Q2 2025), -12% from a year earlier and +3% from the quarter before. Operating margin was -132.1%, net loss $60.3M (121.6% of revenue).
Ginkgo Bioworks Holdings, Q2 2025: revenue $49.6M (-12% year over year), operating margin -132.1%, net loss $60.3M, operating cash flow −$40.3M. The chart follows the revenue to costs, profit and cash.
| Q2 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $49.6M | +3% | -12% |
| Operating profit | −$65.5M | — | — |
| Net earnings | −$60.3M | — | — |
| Operating cash flow | −$40.3M | — | — |
What changed
Revenue was $49.6M in Q2 2025, down 12% year over year and up 3% from the previous quarter.
Operating costs exceeded revenue by $65.5M, an operating margin of -132.1%. Total costs fell 59% while revenue fell 12%. The quarter ended with a net loss of $60.3M, narrower than the previous quarter's $91.0M loss.
Operating cash flow was −$40.3M. Non-cash charges added back $15.2M of depreciation and amortization and $22.2M of share-based compensation. Working capital and other items used $17.4M. Capital expenditures of $38K exceeded it, leaving free cash flow of −$40.3M.
Questions
What was Ginkgo Bioworks Holdings' revenue in the second quarter 2025?
Ginkgo Bioworks Holdings (DNA) reported revenue of $49.6M for the second quarter 2025 (Q2 2025), -12% from a year earlier and +3% from the quarter before.
Was Ginkgo Bioworks Holdings profitable in the second quarter 2025?
Operating loss was $65.5M (-132.1% of revenue) and net loss $60.3M.